Publications by authors named "Ida Contasta"

Claim this Profile
T
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy.
Anna Maria Berghella, Ida Contasta, Roberto Lattanzio, Giancarlo Di Gregorio, Irma Campitelli

Curr Drug Targets· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age.
Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo

Immun Ageing· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates.
Anna Maria Berghella, Ida Contasta, Tiziana Del Beato, Patrizia Pellegrini

Immun Ageing· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Ida Contasta, Rocco Totaro, Patrizia Pellegrini, Tiziana Del Beato, Antonio Carolei

J Transl Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer.
Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, Anna Maria Berghella

Clin Dev Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.
Anna Maria Berghella, Patrizia Pellegrini, Tiziana Del Beato, Fabiana Ciccone, Ida Contasta

Cancer Immunol Immunother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
Patrizia Pellegrini, Anna Maria Berghella, Ida Contasta, Tiziana Del Beato, Domenico Adorno

Cancer Biother Radiopharm· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
Anna Maria Berghella, Ida Contasta, Patrizia Pellegrini, Tiziana Del Beato, Domenico Adorno

Cancer Biother Radiopharm· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.
Ida Contasta, Patrizia Pellegrini, Anna Maria Berghella, Tiziana Del Beato, Domenico Adorno

Cancer Biother Radiopharm· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Patrizia Pellegrini, Rocco Totaro, Ida Contasta, Anna Maria Berghella, Antonio Carolei

Neuroimmunomodulation· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy.
Anna Maria Berghella, Rocco Totaro, Patrizia Pellegrini, Ida Contasta, Tomassina Russo

Neuroimmunomodulation· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effects.
Patrizia Pellegrini, Rocco Totaro, Ida Contasta, Anna Maria Berghella, Tomassina Russo

Clin Neuropharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Patrizia Pellegrini, Anna Maria Berghella, Ida Contasta, Domenico Adorno

Transpl Immunol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Ida Contasta, Anna Maria Berghella, Patrizia Pellegrini, Domenico Adorno

Cancer Biother Radiopharm· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer.
Anna Maria Berghella, Ida Contasta, Patrizia Pellegrini, Tiziana Del Beato, Domenico Adorno

Cancer Biother Radiopharm· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis